Primary materials including interviews with some of the volunteer subjects provide information on the experiments into the pathogenic mechanism of yellow fever.
The bias for publishing positive clinical-research results can cause physicians to question journal articles as dependable sources of product information.
Institutional review boards (IRBs) have the responsibility to ensure the protection of human-research subjects and are legally liable if they fail to do so.
Virtual Mentor spoke with Dr. David Classen about the current state of patient safety in the United States. Dr Classen discussed the goals and challenges of improving patient safety in inpatient and ambulatory settings and how health care reform will impact future efforts to improve patient safety.
Specific contributions to a scientific article entitle the contributor to be included as an author; requests for authorship by those who have not made those specific contributions are unethical.
Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.